Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.265
-0.011 (-3.81%)
Nov 21, 2024, 3:06 PM EST - Market open
Vincerx Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 9 | 25 | 22 | 214 | 292 | - |
| Market Cap Growth | 2.39% | 16.73% | -89.91% | -26.75% | - | - |
| Enterprise Value | 1 | 7 | -41 | 96 | 293 | - |
| Last Close Price | 0.28 | 1.18 | 1.02 | 10.19 | 20.91 | - |
| PB Ratio | 0.95 | 2.25 | 0.45 | 2.14 | 11.52 | - |
| P/TBV Ratio | 2.43 | 2.25 | 0.45 | 2.14 | 11.52 | - |
| Debt / Equity Ratio | 0.18 | 0.22 | 0.07 | 0.04 | - | - |
| Quick Ratio | 2.06 | 2.51 | 5.88 | 8.01 | 1.63 | - |
| Current Ratio | 2.17 | 2.63 | 6.11 | 8.04 | 1.67 | - |
| Return on Equity (ROE) | -211.86% | -136.38% | -85.12% | -62.54% | -131.20% | - |
| Return on Assets (ROA) | -83.27% | -68.72% | -48.54% | -43.30% | - | - |
| Return on Capital (ROIC) | -117.35% | -82.16% | -55.21% | -60.30% | -28.19% | - |
| Earnings Yield | -292.28% | -159.17% | -291.41% | -18.35% | -5.68% | - |
| FCF Yield | -302.39% | -160.34% | -275.77% | -15.71% | -0.78% | - |
| Buyback Yield / Dilution | -49.39% | -1.26% | -22.43% | -227.04% | -17.65% | - |
| Total Shareholder Return | -49.39% | -1.26% | -22.43% | -227.04% | -17.65% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.